Science Signaling-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=569045, encodeId=16aa56904503, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Science Signaling审稿比较快，编辑把关很严格，reviewer给的意见很中肯，提的点很细，小到单词的拼写，很受益，同时也需要补充好多实验数据。有没有已经被接收的前辈，后面需要提供原始数据和细胞鉴定结果吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLQnAMuWcgbnXHKBn6SBwjLqJ87Qb1XOtrZE5zicjIqAxkKWpiaDyjtV6f8yCDq7VH7efLTibptoxFMg/132, createdBy=ba2a2048407, createdName=zxn2011jida, createdTime=Wed Apr 03 11:14:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555609, encodeId=e47255560976, content=请问一下你的文章接收了吗songyu88 2017-03-20 15:56:00 发表: 本月16号投了一篇.现在还在高级编辑手中评估.纠结中///望大侠们指点迷津...., beContent=songyu88 2017-03-20 15:56:00 发表: 本月16号投了一篇.现在还在高级编辑手中评估.纠结中///望大侠们指点迷津...., objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef7e2098647, createdName=pengqiu, createdTime=Wed May 02 00:00:00 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555473, encodeId=7b135554e34e, content=请问一下这个杂志的审稿周期是什么样子的?我的第一天就变成了 to advisor,也不知道什么个情况.谢谢!bigapple001 2018-04-23 12:05:00 发表: science子刊.由于工作太为基础.引用率不高.但是收稿非常苛刻.在信号通路上面需要有重大发现.但是由于if上不去.审稿又很严苛.很多人更加倾向于14分的MC.可以说是一个操作不好的子刊.业内认可度高.但是对于一般人来说.性价比太低...., beContent=bigapple001 2018-04-23 12:05:00 发表: science子刊.由于工作太为基础.引用率不高.但是收稿非常苛刻.在信号通路上面需要有重大发现.但是由于if上不去.审稿又很严苛.很多人更加倾向于14分的MC.可以说是一个操作不好的子刊.业内认可度高.但是对于一般人来说.性价比太低...., objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef7e2098647, createdName=pengqiu, createdTime=Fri Apr 27 00:00:00 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534475, encodeId=a97c5344e5bb, content=本月16号投了一篇，现在还在高级编辑手中评估，纠结中///望大侠们指点迷津。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/dc640585e485c5fe038c05c4aa05a581/6e94a78bc18cd7bb2db4c4d390e4168b.jpg, createdBy=87591945079, createdName=songyu88, createdTime=Mon Mar 20 15:56:00 CST 2017, time=2017-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510691, encodeId=94a151069184, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：我是咨询一下各位前辈，我文章提交已经20天了，状态还是under evaluation，这是什么意思啊，还在Editor那儿吗？怎么既不拒也不送审啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2da1618884, createdName=xuanxuan23, createdTime=Mon Mar 23 09:14:00 CST 2015, time=2015-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505594, encodeId=a5d7505594a8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：编辑把关非常严谨，回复及时，对文章要求较高，整体内容上从整体到细胞机制都需要，所阐述的信号通路要新颖，感觉能中这个，J Neurosci应该也没有问题。 SCIENCE旗下子刊，看好它。其兄弟姐妹期刊，SCI TRANSLATIONAL MED今年已经到14分了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=488, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Aug 26 16:51:00 CST 2014, time=2014-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505381, encodeId=4dfc5053819e, content=审稿速度:3.0 经验分享：太慢了，编辑手里呆了一个月，审稿人手里呆了一个月，还没有音信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=633, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Aug 17 08:37:00 CST 2014, time=2014-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481548, encodeId=ddb8481548ad, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=660, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2019-04-03 zxn2011jida

审稿速度:1.0 | 投稿命中率:25.0
经验分享：Science Signaling审稿比较快，编辑把关很严格，reviewer给的意见很中肯，提的点很细，小到单词的拼写，很受益，同时也需要补充好多实验数据。有没有已经被接收的前辈，后面需要提供原始数据和细胞鉴定结果吗。

206 0

[GetPortalCommentsPageByObjectIdResponse(id=569045, encodeId=16aa56904503, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Science Signaling审稿比较快，编辑把关很严格，reviewer给的意见很中肯，提的点很细，小到单词的拼写，很受益，同时也需要补充好多实验数据。有没有已经被接收的前辈，后面需要提供原始数据和细胞鉴定结果吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLQnAMuWcgbnXHKBn6SBwjLqJ87Qb1XOtrZE5zicjIqAxkKWpiaDyjtV6f8yCDq7VH7efLTibptoxFMg/132, createdBy=ba2a2048407, createdName=zxn2011jida, createdTime=Wed Apr 03 11:14:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555609, encodeId=e47255560976, content=请问一下你的文章接收了吗songyu88 2017-03-20 15:56:00 发表: 本月16号投了一篇.现在还在高级编辑手中评估.纠结中///望大侠们指点迷津...., beContent=songyu88 2017-03-20 15:56:00 发表: 本月16号投了一篇.现在还在高级编辑手中评估.纠结中///望大侠们指点迷津...., objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef7e2098647, createdName=pengqiu, createdTime=Wed May 02 00:00:00 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555473, encodeId=7b135554e34e, content=请问一下这个杂志的审稿周期是什么样子的?我的第一天就变成了 to advisor,也不知道什么个情况.谢谢!bigapple001 2018-04-23 12:05:00 发表: science子刊.由于工作太为基础.引用率不高.但是收稿非常苛刻.在信号通路上面需要有重大发现.但是由于if上不去.审稿又很严苛.很多人更加倾向于14分的MC.可以说是一个操作不好的子刊.业内认可度高.但是对于一般人来说.性价比太低...., beContent=bigapple001 2018-04-23 12:05:00 发表: science子刊.由于工作太为基础.引用率不高.但是收稿非常苛刻.在信号通路上面需要有重大发现.但是由于if上不去.审稿又很严苛.很多人更加倾向于14分的MC.可以说是一个操作不好的子刊.业内认可度高.但是对于一般人来说.性价比太低...., objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef7e2098647, createdName=pengqiu, createdTime=Fri Apr 27 00:00:00 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534475, encodeId=a97c5344e5bb, content=本月16号投了一篇，现在还在高级编辑手中评估，纠结中///望大侠们指点迷津。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/dc640585e485c5fe038c05c4aa05a581/6e94a78bc18cd7bb2db4c4d390e4168b.jpg, createdBy=87591945079, createdName=songyu88, createdTime=Mon Mar 20 15:56:00 CST 2017, time=2017-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510691, encodeId=94a151069184, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：我是咨询一下各位前辈，我文章提交已经20天了，状态还是under evaluation，这是什么意思啊，还在Editor那儿吗？怎么既不拒也不送审啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2da1618884, createdName=xuanxuan23, createdTime=Mon Mar 23 09:14:00 CST 2015, time=2015-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505594, encodeId=a5d7505594a8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：编辑把关非常严谨，回复及时，对文章要求较高，整体内容上从整体到细胞机制都需要，所阐述的信号通路要新颖，感觉能中这个，J Neurosci应该也没有问题。 SCIENCE旗下子刊，看好它。其兄弟姐妹期刊，SCI TRANSLATIONAL MED今年已经到14分了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=488, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Aug 26 16:51:00 CST 2014, time=2014-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505381, encodeId=4dfc5053819e, content=审稿速度:3.0 经验分享：太慢了，编辑手里呆了一个月，审稿人手里呆了一个月，还没有音信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=633, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Aug 17 08:37:00 CST 2014, time=2014-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481548, encodeId=ddb8481548ad, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=660, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2018-05-02 pengqiu

请问一下你的文章接收了吗songyu88 2017-03-20 15:56:00 发表:
本月16号投了一篇.现在还在高级编辑手中评估.纠结中///望大侠们指点迷津....

songyu88 2017-03-20 15:56:00 发表: 本月16号投了一篇.现在还在高级编辑手中评估.纠结中///望大侠们指点迷津....

320 0

[GetPortalCommentsPageByObjectIdResponse(id=569045, encodeId=16aa56904503, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Science Signaling审稿比较快，编辑把关很严格，reviewer给的意见很中肯，提的点很细，小到单词的拼写，很受益，同时也需要补充好多实验数据。有没有已经被接收的前辈，后面需要提供原始数据和细胞鉴定结果吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLQnAMuWcgbnXHKBn6SBwjLqJ87Qb1XOtrZE5zicjIqAxkKWpiaDyjtV6f8yCDq7VH7efLTibptoxFMg/132, createdBy=ba2a2048407, createdName=zxn2011jida, createdTime=Wed Apr 03 11:14:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555609, encodeId=e47255560976, content=请问一下你的文章接收了吗songyu88 2017-03-20 15:56:00 发表: 本月16号投了一篇.现在还在高级编辑手中评估.纠结中///望大侠们指点迷津...., beContent=songyu88 2017-03-20 15:56:00 发表: 本月16号投了一篇.现在还在高级编辑手中评估.纠结中///望大侠们指点迷津...., objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef7e2098647, createdName=pengqiu, createdTime=Wed May 02 00:00:00 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555473, encodeId=7b135554e34e, content=请问一下这个杂志的审稿周期是什么样子的?我的第一天就变成了 to advisor,也不知道什么个情况.谢谢!bigapple001 2018-04-23 12:05:00 发表: science子刊.由于工作太为基础.引用率不高.但是收稿非常苛刻.在信号通路上面需要有重大发现.但是由于if上不去.审稿又很严苛.很多人更加倾向于14分的MC.可以说是一个操作不好的子刊.业内认可度高.但是对于一般人来说.性价比太低...., beContent=bigapple001 2018-04-23 12:05:00 发表: science子刊.由于工作太为基础.引用率不高.但是收稿非常苛刻.在信号通路上面需要有重大发现.但是由于if上不去.审稿又很严苛.很多人更加倾向于14分的MC.可以说是一个操作不好的子刊.业内认可度高.但是对于一般人来说.性价比太低...., objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef7e2098647, createdName=pengqiu, createdTime=Fri Apr 27 00:00:00 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534475, encodeId=a97c5344e5bb, content=本月16号投了一篇，现在还在高级编辑手中评估，纠结中///望大侠们指点迷津。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/dc640585e485c5fe038c05c4aa05a581/6e94a78bc18cd7bb2db4c4d390e4168b.jpg, createdBy=87591945079, createdName=songyu88, createdTime=Mon Mar 20 15:56:00 CST 2017, time=2017-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510691, encodeId=94a151069184, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：我是咨询一下各位前辈，我文章提交已经20天了，状态还是under evaluation，这是什么意思啊，还在Editor那儿吗？怎么既不拒也不送审啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2da1618884, createdName=xuanxuan23, createdTime=Mon Mar 23 09:14:00 CST 2015, time=2015-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505594, encodeId=a5d7505594a8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：编辑把关非常严谨，回复及时，对文章要求较高，整体内容上从整体到细胞机制都需要，所阐述的信号通路要新颖，感觉能中这个，J Neurosci应该也没有问题。 SCIENCE旗下子刊，看好它。其兄弟姐妹期刊，SCI TRANSLATIONAL MED今年已经到14分了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=488, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Aug 26 16:51:00 CST 2014, time=2014-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505381, encodeId=4dfc5053819e, content=审稿速度:3.0 经验分享：太慢了，编辑手里呆了一个月，审稿人手里呆了一个月，还没有音信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=633, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Aug 17 08:37:00 CST 2014, time=2014-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481548, encodeId=ddb8481548ad, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=660, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2018-04-27 pengqiu

请问一下这个杂志的审稿周期是什么样子的?我的第一天就变成了 to advisor,也不知道什么个情况.谢谢!bigapple001 2018-04-23 12:05:00 发表:
science子刊.由于工作太为基础.引用率不高.但是收稿非常苛刻.在信号通路上面需要有重大发现.但是由于if上不去.审稿又很严苛.很多人更加倾向于14分的MC.可以说是一个操作不好的子刊.业内认可度高.但是对于一般人来说.性价比太低....

bigapple001 2018-04-23 12:05:00 发表: science子刊.由于工作太为基础.引用率不高.但是收稿非常苛刻.在信号通路上面需要有重大发现.但是由于if上不去.审稿又很严苛.很多人更加倾向于14分的MC.可以说是一个操作不好的子刊.业内认可度高.但是对于一般人来说.性价比太低....

356 0

[GetPortalCommentsPageByObjectIdResponse(id=569045, encodeId=16aa56904503, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Science Signaling审稿比较快，编辑把关很严格，reviewer给的意见很中肯，提的点很细，小到单词的拼写，很受益，同时也需要补充好多实验数据。有没有已经被接收的前辈，后面需要提供原始数据和细胞鉴定结果吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLQnAMuWcgbnXHKBn6SBwjLqJ87Qb1XOtrZE5zicjIqAxkKWpiaDyjtV6f8yCDq7VH7efLTibptoxFMg/132, createdBy=ba2a2048407, createdName=zxn2011jida, createdTime=Wed Apr 03 11:14:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555609, encodeId=e47255560976, content=请问一下你的文章接收了吗songyu88 2017-03-20 15:56:00 发表: 本月16号投了一篇.现在还在高级编辑手中评估.纠结中///望大侠们指点迷津...., beContent=songyu88 2017-03-20 15:56:00 发表: 本月16号投了一篇.现在还在高级编辑手中评估.纠结中///望大侠们指点迷津...., objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef7e2098647, createdName=pengqiu, createdTime=Wed May 02 00:00:00 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555473, encodeId=7b135554e34e, content=请问一下这个杂志的审稿周期是什么样子的?我的第一天就变成了 to advisor,也不知道什么个情况.谢谢!bigapple001 2018-04-23 12:05:00 发表: science子刊.由于工作太为基础.引用率不高.但是收稿非常苛刻.在信号通路上面需要有重大发现.但是由于if上不去.审稿又很严苛.很多人更加倾向于14分的MC.可以说是一个操作不好的子刊.业内认可度高.但是对于一般人来说.性价比太低...., beContent=bigapple001 2018-04-23 12:05:00 发表: science子刊.由于工作太为基础.引用率不高.但是收稿非常苛刻.在信号通路上面需要有重大发现.但是由于if上不去.审稿又很严苛.很多人更加倾向于14分的MC.可以说是一个操作不好的子刊.业内认可度高.但是对于一般人来说.性价比太低...., objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef7e2098647, createdName=pengqiu, createdTime=Fri Apr 27 00:00:00 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534475, encodeId=a97c5344e5bb, content=本月16号投了一篇，现在还在高级编辑手中评估，纠结中///望大侠们指点迷津。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/dc640585e485c5fe038c05c4aa05a581/6e94a78bc18cd7bb2db4c4d390e4168b.jpg, createdBy=87591945079, createdName=songyu88, createdTime=Mon Mar 20 15:56:00 CST 2017, time=2017-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510691, encodeId=94a151069184, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：我是咨询一下各位前辈，我文章提交已经20天了，状态还是under evaluation，这是什么意思啊，还在Editor那儿吗？怎么既不拒也不送审啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2da1618884, createdName=xuanxuan23, createdTime=Mon Mar 23 09:14:00 CST 2015, time=2015-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505594, encodeId=a5d7505594a8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：编辑把关非常严谨，回复及时，对文章要求较高，整体内容上从整体到细胞机制都需要，所阐述的信号通路要新颖，感觉能中这个，J Neurosci应该也没有问题。 SCIENCE旗下子刊，看好它。其兄弟姐妹期刊，SCI TRANSLATIONAL MED今年已经到14分了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=488, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Aug 26 16:51:00 CST 2014, time=2014-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505381, encodeId=4dfc5053819e, content=审稿速度:3.0 经验分享：太慢了，编辑手里呆了一个月，审稿人手里呆了一个月，还没有音信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=633, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Aug 17 08:37:00 CST 2014, time=2014-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481548, encodeId=ddb8481548ad, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=660, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2017-03-20 songyu88

本月16号投了一篇，现在还在高级编辑手中评估，纠结中///望大侠们指点迷津。。。。

491 0

[GetPortalCommentsPageByObjectIdResponse(id=569045, encodeId=16aa56904503, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Science Signaling审稿比较快，编辑把关很严格，reviewer给的意见很中肯，提的点很细，小到单词的拼写，很受益，同时也需要补充好多实验数据。有没有已经被接收的前辈，后面需要提供原始数据和细胞鉴定结果吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLQnAMuWcgbnXHKBn6SBwjLqJ87Qb1XOtrZE5zicjIqAxkKWpiaDyjtV6f8yCDq7VH7efLTibptoxFMg/132, createdBy=ba2a2048407, createdName=zxn2011jida, createdTime=Wed Apr 03 11:14:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555609, encodeId=e47255560976, content=请问一下你的文章接收了吗songyu88 2017-03-20 15:56:00 发表: 本月16号投了一篇.现在还在高级编辑手中评估.纠结中///望大侠们指点迷津...., beContent=songyu88 2017-03-20 15:56:00 发表: 本月16号投了一篇.现在还在高级编辑手中评估.纠结中///望大侠们指点迷津...., objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef7e2098647, createdName=pengqiu, createdTime=Wed May 02 00:00:00 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555473, encodeId=7b135554e34e, content=请问一下这个杂志的审稿周期是什么样子的?我的第一天就变成了 to advisor,也不知道什么个情况.谢谢!bigapple001 2018-04-23 12:05:00 发表: science子刊.由于工作太为基础.引用率不高.但是收稿非常苛刻.在信号通路上面需要有重大发现.但是由于if上不去.审稿又很严苛.很多人更加倾向于14分的MC.可以说是一个操作不好的子刊.业内认可度高.但是对于一般人来说.性价比太低...., beContent=bigapple001 2018-04-23 12:05:00 发表: science子刊.由于工作太为基础.引用率不高.但是收稿非常苛刻.在信号通路上面需要有重大发现.但是由于if上不去.审稿又很严苛.很多人更加倾向于14分的MC.可以说是一个操作不好的子刊.业内认可度高.但是对于一般人来说.性价比太低...., objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef7e2098647, createdName=pengqiu, createdTime=Fri Apr 27 00:00:00 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534475, encodeId=a97c5344e5bb, content=本月16号投了一篇，现在还在高级编辑手中评估，纠结中///望大侠们指点迷津。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/dc640585e485c5fe038c05c4aa05a581/6e94a78bc18cd7bb2db4c4d390e4168b.jpg, createdBy=87591945079, createdName=songyu88, createdTime=Mon Mar 20 15:56:00 CST 2017, time=2017-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510691, encodeId=94a151069184, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：我是咨询一下各位前辈，我文章提交已经20天了，状态还是under evaluation，这是什么意思啊，还在Editor那儿吗？怎么既不拒也不送审啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2da1618884, createdName=xuanxuan23, createdTime=Mon Mar 23 09:14:00 CST 2015, time=2015-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505594, encodeId=a5d7505594a8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：编辑把关非常严谨，回复及时，对文章要求较高，整体内容上从整体到细胞机制都需要，所阐述的信号通路要新颖，感觉能中这个，J Neurosci应该也没有问题。 SCIENCE旗下子刊，看好它。其兄弟姐妹期刊，SCI TRANSLATIONAL MED今年已经到14分了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=488, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Aug 26 16:51:00 CST 2014, time=2014-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505381, encodeId=4dfc5053819e, content=审稿速度:3.0 经验分享：太慢了，编辑手里呆了一个月，审稿人手里呆了一个月，还没有音信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=633, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Aug 17 08:37:00 CST 2014, time=2014-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481548, encodeId=ddb8481548ad, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=660, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2015-03-23 xuanxuan23

审稿速度:3.0 | 投稿命中率:25.0
经验分享：我是咨询一下各位前辈，我文章提交已经20天了，状态还是under evaluation，这是什么意思啊，还在Editor那儿吗？怎么既不拒也不送审啊？

522 0

[GetPortalCommentsPageByObjectIdResponse(id=569045, encodeId=16aa56904503, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Science Signaling审稿比较快，编辑把关很严格，reviewer给的意见很中肯，提的点很细，小到单词的拼写，很受益，同时也需要补充好多实验数据。有没有已经被接收的前辈，后面需要提供原始数据和细胞鉴定结果吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLQnAMuWcgbnXHKBn6SBwjLqJ87Qb1XOtrZE5zicjIqAxkKWpiaDyjtV6f8yCDq7VH7efLTibptoxFMg/132, createdBy=ba2a2048407, createdName=zxn2011jida, createdTime=Wed Apr 03 11:14:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555609, encodeId=e47255560976, content=请问一下你的文章接收了吗songyu88 2017-03-20 15:56:00 发表: 本月16号投了一篇.现在还在高级编辑手中评估.纠结中///望大侠们指点迷津...., beContent=songyu88 2017-03-20 15:56:00 发表: 本月16号投了一篇.现在还在高级编辑手中评估.纠结中///望大侠们指点迷津...., objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef7e2098647, createdName=pengqiu, createdTime=Wed May 02 00:00:00 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555473, encodeId=7b135554e34e, content=请问一下这个杂志的审稿周期是什么样子的?我的第一天就变成了 to advisor,也不知道什么个情况.谢谢!bigapple001 2018-04-23 12:05:00 发表: science子刊.由于工作太为基础.引用率不高.但是收稿非常苛刻.在信号通路上面需要有重大发现.但是由于if上不去.审稿又很严苛.很多人更加倾向于14分的MC.可以说是一个操作不好的子刊.业内认可度高.但是对于一般人来说.性价比太低...., beContent=bigapple001 2018-04-23 12:05:00 发表: science子刊.由于工作太为基础.引用率不高.但是收稿非常苛刻.在信号通路上面需要有重大发现.但是由于if上不去.审稿又很严苛.很多人更加倾向于14分的MC.可以说是一个操作不好的子刊.业内认可度高.但是对于一般人来说.性价比太低...., objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef7e2098647, createdName=pengqiu, createdTime=Fri Apr 27 00:00:00 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534475, encodeId=a97c5344e5bb, content=本月16号投了一篇，现在还在高级编辑手中评估，纠结中///望大侠们指点迷津。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/dc640585e485c5fe038c05c4aa05a581/6e94a78bc18cd7bb2db4c4d390e4168b.jpg, createdBy=87591945079, createdName=songyu88, createdTime=Mon Mar 20 15:56:00 CST 2017, time=2017-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510691, encodeId=94a151069184, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：我是咨询一下各位前辈，我文章提交已经20天了，状态还是under evaluation，这是什么意思啊，还在Editor那儿吗？怎么既不拒也不送审啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2da1618884, createdName=xuanxuan23, createdTime=Mon Mar 23 09:14:00 CST 2015, time=2015-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505594, encodeId=a5d7505594a8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：编辑把关非常严谨，回复及时，对文章要求较高，整体内容上从整体到细胞机制都需要，所阐述的信号通路要新颖，感觉能中这个，J Neurosci应该也没有问题。 SCIENCE旗下子刊，看好它。其兄弟姐妹期刊，SCI TRANSLATIONAL MED今年已经到14分了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=488, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Aug 26 16:51:00 CST 2014, time=2014-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505381, encodeId=4dfc5053819e, content=审稿速度:3.0 经验分享：太慢了，编辑手里呆了一个月，审稿人手里呆了一个月，还没有音信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=633, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Aug 17 08:37:00 CST 2014, time=2014-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481548, encodeId=ddb8481548ad, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=660, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2014-08-26 匿名用户

审稿速度:3.0 | 投稿命中率:25.0
经验分享：编辑把关非常严谨，回复及时，对文章要求较高，整体内容上从整体到细胞机制都需要，所阐述的信号通路要新颖，感觉能中这个，J Neurosci应该也没有问题。

SCIENCE旗下子刊，看好它。其兄弟姐妹期刊，SCI TRANSLATIONAL MED今年已经到14分了。

488 0

[GetPortalCommentsPageByObjectIdResponse(id=569045, encodeId=16aa56904503, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Science Signaling审稿比较快，编辑把关很严格，reviewer给的意见很中肯，提的点很细，小到单词的拼写，很受益，同时也需要补充好多实验数据。有没有已经被接收的前辈，后面需要提供原始数据和细胞鉴定结果吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLQnAMuWcgbnXHKBn6SBwjLqJ87Qb1XOtrZE5zicjIqAxkKWpiaDyjtV6f8yCDq7VH7efLTibptoxFMg/132, createdBy=ba2a2048407, createdName=zxn2011jida, createdTime=Wed Apr 03 11:14:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555609, encodeId=e47255560976, content=请问一下你的文章接收了吗songyu88 2017-03-20 15:56:00 发表: 本月16号投了一篇.现在还在高级编辑手中评估.纠结中///望大侠们指点迷津...., beContent=songyu88 2017-03-20 15:56:00 发表: 本月16号投了一篇.现在还在高级编辑手中评估.纠结中///望大侠们指点迷津...., objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef7e2098647, createdName=pengqiu, createdTime=Wed May 02 00:00:00 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555473, encodeId=7b135554e34e, content=请问一下这个杂志的审稿周期是什么样子的?我的第一天就变成了 to advisor,也不知道什么个情况.谢谢!bigapple001 2018-04-23 12:05:00 发表: science子刊.由于工作太为基础.引用率不高.但是收稿非常苛刻.在信号通路上面需要有重大发现.但是由于if上不去.审稿又很严苛.很多人更加倾向于14分的MC.可以说是一个操作不好的子刊.业内认可度高.但是对于一般人来说.性价比太低...., beContent=bigapple001 2018-04-23 12:05:00 发表: science子刊.由于工作太为基础.引用率不高.但是收稿非常苛刻.在信号通路上面需要有重大发现.但是由于if上不去.审稿又很严苛.很多人更加倾向于14分的MC.可以说是一个操作不好的子刊.业内认可度高.但是对于一般人来说.性价比太低...., objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef7e2098647, createdName=pengqiu, createdTime=Fri Apr 27 00:00:00 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534475, encodeId=a97c5344e5bb, content=本月16号投了一篇，现在还在高级编辑手中评估，纠结中///望大侠们指点迷津。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/dc640585e485c5fe038c05c4aa05a581/6e94a78bc18cd7bb2db4c4d390e4168b.jpg, createdBy=87591945079, createdName=songyu88, createdTime=Mon Mar 20 15:56:00 CST 2017, time=2017-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510691, encodeId=94a151069184, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：我是咨询一下各位前辈，我文章提交已经20天了，状态还是under evaluation，这是什么意思啊，还在Editor那儿吗？怎么既不拒也不送审啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2da1618884, createdName=xuanxuan23, createdTime=Mon Mar 23 09:14:00 CST 2015, time=2015-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505594, encodeId=a5d7505594a8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：编辑把关非常严谨，回复及时，对文章要求较高，整体内容上从整体到细胞机制都需要，所阐述的信号通路要新颖，感觉能中这个，J Neurosci应该也没有问题。 SCIENCE旗下子刊，看好它。其兄弟姐妹期刊，SCI TRANSLATIONAL MED今年已经到14分了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=488, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Aug 26 16:51:00 CST 2014, time=2014-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505381, encodeId=4dfc5053819e, content=审稿速度:3.0 经验分享：太慢了，编辑手里呆了一个月，审稿人手里呆了一个月，还没有音信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=633, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Aug 17 08:37:00 CST 2014, time=2014-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481548, encodeId=ddb8481548ad, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=660, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2014-08-17 匿名用户

审稿速度:3.0
经验分享：太慢了，编辑手里呆了一个月，审稿人手里呆了一个月，还没有音信

633 0

[GetPortalCommentsPageByObjectIdResponse(id=569045, encodeId=16aa56904503, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：Science Signaling审稿比较快，编辑把关很严格，reviewer给的意见很中肯，提的点很细，小到单词的拼写，很受益，同时也需要补充好多实验数据。有没有已经被接收的前辈，后面需要提供原始数据和细胞鉴定结果吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLQnAMuWcgbnXHKBn6SBwjLqJ87Qb1XOtrZE5zicjIqAxkKWpiaDyjtV6f8yCDq7VH7efLTibptoxFMg/132, createdBy=ba2a2048407, createdName=zxn2011jida, createdTime=Wed Apr 03 11:14:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555609, encodeId=e47255560976, content=请问一下你的文章接收了吗songyu88 2017-03-20 15:56:00 发表: 本月16号投了一篇.现在还在高级编辑手中评估.纠结中///望大侠们指点迷津...., beContent=songyu88 2017-03-20 15:56:00 发表: 本月16号投了一篇.现在还在高级编辑手中评估.纠结中///望大侠们指点迷津...., objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef7e2098647, createdName=pengqiu, createdTime=Wed May 02 00:00:00 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555473, encodeId=7b135554e34e, content=请问一下这个杂志的审稿周期是什么样子的?我的第一天就变成了 to advisor,也不知道什么个情况.谢谢!bigapple001 2018-04-23 12:05:00 发表: science子刊.由于工作太为基础.引用率不高.但是收稿非常苛刻.在信号通路上面需要有重大发现.但是由于if上不去.审稿又很严苛.很多人更加倾向于14分的MC.可以说是一个操作不好的子刊.业内认可度高.但是对于一般人来说.性价比太低...., beContent=bigapple001 2018-04-23 12:05:00 发表: science子刊.由于工作太为基础.引用率不高.但是收稿非常苛刻.在信号通路上面需要有重大发现.但是由于if上不去.审稿又很严苛.很多人更加倾向于14分的MC.可以说是一个操作不好的子刊.业内认可度高.但是对于一般人来说.性价比太低...., objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef7e2098647, createdName=pengqiu, createdTime=Fri Apr 27 00:00:00 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534475, encodeId=a97c5344e5bb, content=本月16号投了一篇，现在还在高级编辑手中评估，纠结中///望大侠们指点迷津。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/dc640585e485c5fe038c05c4aa05a581/6e94a78bc18cd7bb2db4c4d390e4168b.jpg, createdBy=87591945079, createdName=songyu88, createdTime=Mon Mar 20 15:56:00 CST 2017, time=2017-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510691, encodeId=94a151069184, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：我是咨询一下各位前辈，我文章提交已经20天了，状态还是under evaluation，这是什么意思啊，还在Editor那儿吗？怎么既不拒也不送审啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2da1618884, createdName=xuanxuan23, createdTime=Mon Mar 23 09:14:00 CST 2015, time=2015-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505594, encodeId=a5d7505594a8, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：编辑把关非常严谨，回复及时，对文章要求较高，整体内容上从整体到细胞机制都需要，所阐述的信号通路要新颖，感觉能中这个，J Neurosci应该也没有问题。 SCIENCE旗下子刊，看好它。其兄弟姐妹期刊，SCI TRANSLATIONAL MED今年已经到14分了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=488, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Aug 26 16:51:00 CST 2014, time=2014-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505381, encodeId=4dfc5053819e, content=审稿速度:3.0 经验分享：太慢了，编辑手里呆了一个月，审稿人手里呆了一个月，还没有音信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=633, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Aug 17 08:37:00 CST 2014, time=2014-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481548, encodeId=ddb8481548ad, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=660, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2011-06-29 medwu

看涨哦，明年会不会再涨？

660 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务